TD
Translational Development Acquisition Corp.
TDAC · NASDAQ
$10.85 -0.05% (-$0.01)
1M -0.18%
Market Cap $267.1M
P/E Ratio 48.25x
Div. Yield -
ROE 3.28%
Piotroski F-Score Weak
3/9Valuation
33 /100
Expensive P/E 48.25x
P/B 1.79x
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
36 /100
Average ROE 3.28%
ROA 3.52%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.06x
Debt/Equity N/A
Int. coverage N/A
Stability
5 /100
Unstable Beta 0.01x
EPS volatility 1,558.73%
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TDAC
Online
Sector
Financial Services
Industry
Shell Companies
CEO
Michael Hoffman
Employees
2
Headquarters
New York City